SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 119,600
+200 (0.17%)
Last updated: Jan 29, 2026, 2:14 PM KST
9.52% (1Y)
| Market Cap | 9.35T |
| Revenue (ttm) | 675.41B +32.1% |
| Net Income | 320.47B +458.5% |
| EPS | 4,092.19 +458.8% |
| Shares Out | 78.31M |
| PE Ratio | 29.18 |
| Forward PE | 37.79 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 233,677 |
| Average Volume | 227,097 |
| Open | 120,300 |
| Previous Close | 119,400 |
| Day's Range | 118,000 - 122,400 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.83 |
| RSI | 42.35 |
| Earnings Date | Feb 4, 2026 |